Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that has been approved for the treatment of obesity and type 2 diabetes. It works through several mechanisms to promote weight loss and improve glycemic control. …